Immunocore Holdings PLCNASDAQ:IMCR
- LAST PRICE50.6700
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots20.3700/ 1
- Ask / Lots80.5600/ 1
- Open / Previous Close0.0000 / 50.6700
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IMCR |
|---|---|---|
| 09:32 ET | 264 | 50.97 |
| 09:38 ET | 100 | 51.36 |
| 09:39 ET | 390 | 51.35 |
| 09:43 ET | 475 | 50.77 |
| 09:45 ET | 1700 | 51.475 |
| 09:48 ET | 800 | 51.19 |
| 09:56 ET | 100 | 50.77 |
| 09:57 ET | 13854 | 50.65 |
| 09:59 ET | 300 | 50.92 |
| 10:01 ET | 2681 | 50.905 |
| 10:03 ET | 1126 | 50.4603 |
| 10:06 ET | 200 | 50.695 |
| 10:08 ET | 100 | 50.695 |
| 10:15 ET | 100 | 50.805 |
| 10:17 ET | 262 | 50.835 |
| 10:21 ET | 1000 | 50.71 |
| 10:24 ET | 300 | 50.705 |
| 10:33 ET | 405 | 50.94 |
| 10:35 ET | 3206 | 50.77 |
| 10:37 ET | 200 | 50.78 |
| 10:39 ET | 100 | 50.92 |
| 10:42 ET | 100 | 50.64 |
| 10:48 ET | 100 | 50.74 |
| 10:51 ET | 375 | 50.52 |
| 10:53 ET | 100 | 50.45 |
| 11:06 ET | 100 | 50.42 |
| 11:08 ET | 1000 | 50.3 |
| 11:09 ET | 200 | 50.18 |
| 11:11 ET | 275 | 50.291 |
| 11:13 ET | 200 | 50.29 |
| 11:22 ET | 300 | 50.39 |
| 11:38 ET | 100 | 50.37 |
| 11:47 ET | 400 | 50.29 |
| 11:49 ET | 11600 | 50.23 |
| 11:51 ET | 100 | 50.155 |
| 11:54 ET | 200 | 50.34 |
| 12:02 ET | 400 | 50.21 |
| 12:09 ET | 1216 | 49.985 |
| 12:16 ET | 100 | 50.11 |
| 12:18 ET | 240 | 49.98 |
| 12:21 ET | 100 | 49.89 |
| 12:23 ET | 400 | 49.83 |
| 12:25 ET | 100 | 49.74 |
| 12:27 ET | 1508 | 50.09 |
| 12:30 ET | 100 | 50.1 |
| 12:32 ET | 300 | 50.3 |
| 12:41 ET | 600 | 50.37 |
| 12:48 ET | 710 | 50.325 |
| 12:52 ET | 300 | 50.16 |
| 12:54 ET | 100 | 50.08 |
| 01:08 ET | 100 | 50.18 |
| 01:10 ET | 100 | 50.27 |
| 01:14 ET | 100 | 50.29 |
| 01:17 ET | 100 | 50.24 |
| 01:21 ET | 300 | 50.07 |
| 01:28 ET | 200 | 50.16 |
| 01:32 ET | 100 | 50.13 |
| 01:39 ET | 1300 | 50.135 |
| 01:48 ET | 153 | 50.1 |
| 01:53 ET | 923 | 50.105 |
| 01:55 ET | 603 | 50.1 |
| 02:00 ET | 300 | 50.01 |
| 02:04 ET | 248 | 50 |
| 02:06 ET | 100 | 50.09 |
| 02:13 ET | 100 | 50.035 |
| 02:18 ET | 300 | 50.1 |
| 02:20 ET | 900 | 50.1 |
| 02:22 ET | 800 | 50.24 |
| 02:26 ET | 200 | 50.34 |
| 02:27 ET | 200 | 50.49 |
| 02:29 ET | 600 | 50.35 |
| 02:31 ET | 300 | 50.44 |
| 02:33 ET | 100 | 50.44 |
| 02:36 ET | 1000 | 50.48 |
| 02:38 ET | 500 | 50.305 |
| 02:42 ET | 600 | 50.41 |
| 02:44 ET | 200 | 50.435 |
| 02:45 ET | 200 | 50.47 |
| 02:47 ET | 100 | 50.62 |
| 02:49 ET | 200 | 50.34 |
| 02:51 ET | 400 | 50.52 |
| 02:54 ET | 200 | 50.46 |
| 02:56 ET | 2998 | 50.36 |
| 02:58 ET | 400 | 50.37 |
| 03:02 ET | 970 | 50.48 |
| 03:03 ET | 200 | 50.54 |
| 03:05 ET | 100 | 50.62 |
| 03:07 ET | 39965 | 50.72 |
| 03:09 ET | 200 | 50.79 |
| 03:12 ET | 867 | 50.83 |
| 03:14 ET | 100 | 50.92 |
| 03:16 ET | 200 | 50.91 |
| 03:18 ET | 7900 | 50.915 |
| 03:20 ET | 300 | 51.09 |
| 03:21 ET | 200 | 51.09 |
| 03:23 ET | 500 | 51.02 |
| 03:25 ET | 2700 | 50.87 |
| 03:27 ET | 400 | 50.97 |
| 03:30 ET | 3560 | 50.755 |
| 03:34 ET | 500 | 50.785 |
| 03:36 ET | 400 | 50.86 |
| 03:38 ET | 400 | 50.72 |
| 03:39 ET | 700 | 50.68 |
| 03:41 ET | 100 | 50.7 |
| 03:43 ET | 688 | 50.59 |
| 03:45 ET | 793 | 50.82 |
| 03:48 ET | 400 | 50.8 |
| 03:50 ET | 1000 | 50.74 |
| 03:52 ET | 2640 | 50.82 |
| 03:54 ET | 1117 | 50.88 |
| 03:56 ET | 12100 | 50.78 |
| 03:57 ET | 3570 | 50.77 |
| 03:59 ET | 12425 | 50.67 |
Sep 22, 2023
DJ 13D Filings -- Barron's, from 9:30PM ET on Friday Sep 22, 2023 by Dow Jones
9:30PM ET on Friday Sep 22, 2023 by Dow JonesDJ Cardlytics, Immunocore, and More Stocks See Action From Activist Investors -- Barrons.com, from 6:40PM ET on Friday Sep 22, 2023 by Dow Jones
6:40PM ET on Friday Sep 22, 2023 by Dow Jones
Sep 21, 2023
DJ Immunocore Holdings Is Maintained at Outperform by Oppenheimer, from 9:27AM ET on Thursday Sep 21, 2023 by Dow Jones
9:27AM ET on Thursday Sep 21, 2023 by Dow Jones
Sep 13, 2023
DJ Immunocore Holdings Initiated at Buy by Needham, from 6:33AM ET on Wednesday Sep 13, 2023 by Dow Jones
6:33AM ET on Wednesday Sep 13, 2023 by Dow Jones
Sep 11, 2023
Immunocore to present at upcoming investor conferences, from 5:00PM ET on Monday Sep 11, 2023 by Dow Jones
5:00PM ET on Monday Sep 11, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Immunocore Holdings PLC | 2.5B | -40.2x | --- |
Blueprint Medicines Corp | 3.0B | -5.4x | --- |
Arrowhead Pharmaceuticals Inc | 2.8B | -15.4x | --- |
Denali Therapeutics Inc | 3.0B | -19.9x | --- |
Zai Lab Ltd | 2.5B | -6.2x | --- |
Cytokinetics Inc | 2.9B | -5.3x | --- |
Company Information
Immunocore Holdings plc is a commercial-stage biotechnology company. The Company is engaged in the development of a class of T cell receptor (TCR), bispecific immunotherapies called immune mobilizing monoclonal TCRs Against X disease (ImmTAX), which is designed to treat a range of diseases, including cancer, infectious and autoimmune. It is developing a pipeline in multiple therapeutic areas, including five clinical stage programs in oncology and infectious disease, advanced pre-clinical programs in autoimmune disease and multiple earlier pre-clinical programs. Its lead product, KIMMTRAK, is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma (mUM), in the United States, European Union, Canada, Australia, and the United Kingdom. Its pipeline products include IMC-F106C, IMC-C103C, IMC-I109V, and IMC-M113V, among others. Its clinical programs are being conducted with patients with a range of cancers including melanoma, lung, gastric, and others.
Contact Information
- Headquarters
- 90 Park Drive, Milton Park, AbingdonABINGDON, United Kingdom OX14 4RY
- Phone
- 123-543-8600
- Fax
- ---
Executives
- Independent Chairman of the Board
- John Bell
- Chief Executive Officer, Director
- Bahija Jallal
- Chief Financial Officer, Head of Strategy
- Brian Di Donato
- Chief Human Resource Officer
- Tina St Leger
- Head of Research and Development
- David Berman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.5B |
|---|---|
Revenue (TTM) | $220.3M |
Shares Outstanding | 48.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.26 |
Book Value | $7.03 |
P/E Ratio | -40.2x |
Price/Sales (TTM) | 11.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -27.16% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
